Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18F PET/CT in prostate cancer patients in early biochemical failure-Reference-Cited by-同舟云学术

Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18F PET/CT in prostate cancer patients in early biochemical failure

Published:2022-12-16 Issue:3 Volume:44 Page:187-193
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Maliha Peter George,Nolet Benoit,Ebrahim Anwar,Abikhzer Gad,Chaussé Guillaume,Bahoric Boris,Niazi Tamim,Probst Stephan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference26 articles.

1. Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy.;Eiber;J Nucl Med,2015

2. (18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.;Calais;Lancet Oncol,2019

3. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial.;Fendler;JAMA Oncol,2019

4. Diagnostic performance of (18)F-DCFPyL-PET/CT in men with biochemically recurrent prostate cancer: results from the CONDOR phase III, multicenter study.;Morris;Clin Cancer Res,2021

5. A phase 2/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY).;Pienta;J Urol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting;Clinical and Translational Imaging;2024-08-05

2. Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2;Clinical and Translational Imaging;2024-07-18

3. Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment;Diagnostics;2023-11-26

4. Feasibility of One-Day PET/CT Scanning Protocol with ⁶⁸Ga-DOTA-FAPI-04 and ¹⁸F-FDG for the Detection of Ovarian Cancer Recurrence and Metastasis;Cancer Biotherapy and Radiopharmaceuticals;2023-10-26